Primary information |
---|
sequence ID | Seq_2822 |
Peptide sequence | GLDEDSDRAIEG |
CancerPDF_ID | CancerPDF_ID9896, CancerPDF_ID11490, |
PMID | 21533267,26992070 |
Protein Name | Prothrombin,Prothrombin |
UniprotKB Entry Name | THRB_HUMAN,THRB_HUMAN |
Fluid | Serum,Serum |
M/Z | 638.78,1275.5579 |
Charge | 2,NA |
Mass (in Da) | NA,1276.569261 |
fdr | NA,NA |
Profiling Technique | LC-MS,LC-MS |
Peptide Identification technique | LC/MS/MS,LC-MS/MS |
Quantification Technique | Multiple Reaction Monitoring,NA |
Labelled/Label Free | Label Free,Label Free |
FDR | 1.49,FDR 1 % |
CancerPDF_ID | CancerPDF_ID9896, CancerPDF_ID11490, |
p-Value | NA,NA |
Software | MASCOT,SEQUEST and Maxquant |
Length | 12,12 |
Cancer Type | Lung adenocarcinoma,Melanoma |
Database | Swissprot Database (57.4),SwissProt Database |
Modification | NA,NA |
Number of Patients | 62 lung adenocarcinoma and 30 healthy control,8 cancer samples and 4 healthy samples |
Regulation | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal","Present in 1 cancer samples out of 8 cancer samples. ,Present in 0 healthy samples out of 4 healthy samples." |
Validation | MRM-based validation of 19 candidates,na |
Sensitivity | NA,NA |
Specificity | NA,NA |
Accuracy | NA,NA |
Peptide Atlas | NA |
IEDB | |